Expression Pathology Inc. (EPI) is a private biotechnology company leading the development of innovative tissue protein analysis methods for research and diagnostic applications.

The company’s proprietary “tissue microproteomics” technologies have already been adopted by major academic and industrial researchers worldwide, enabling discovery and analysis of protein biomarkers in tissue employing the latest advances in mass spectrometry. Formalin-fixed and paraffin-embedded (FFPE) tissue samples are routinely collected, tested and archived in medical treatment and research facilities. They constitute a huge untapped resource for discovery, validation and accurate measurement of biomarkers of disease progression and recurrence, drug response and toxicity. Expression Pathology’s Liquid Tissue® sample preparation and Director™ laser microdissection technologies are opening new ways to extract valuable protein information from FFPE tissue.

Financials

People